Amsterdam - Delayed Quote EUR

Corbion N.V. (CRBN.AS)

18.92 -0.06 (-0.32%)
At close: 5:35 PM GMT+2
Loading Chart for CRBN.AS
DELL
  • Previous Close 18.98
  • Open 19.20
  • Bid --
  • Ask --
  • Day's Range 18.86 - 19.20
  • 52 Week Range 14.54 - 30.38
  • Volume 70,089
  • Avg. Volume 128,471
  • Market Cap (intraday) 1.118B
  • Beta (5Y Monthly) 0.94
  • PE Ratio (TTM) 15.51
  • EPS (TTM) 1.22
  • Earnings Date Apr 24, 2024 - Apr 29, 2024
  • Forward Dividend & Yield 0.61 (3.21%)
  • Ex-Dividend Date May 17, 2024
  • 1y Target Est 24.40

Corbion N.V. provides lactic acid and lactic acid derivatives, other ferment, functional enzyme blends, minerals, vitamins, and algae ingredients worldwide. It offers ingredient solutions for the food, home and personal care, animal nutrition, supplements, pharmaceuticals, medical devices, and bioplastics markets. The company markets its products through a network of sales offices and distributors. The company was formerly known as CSM N.V. and changed its name to Corbion N.V. in October 2013. Corbion N.V. was incorporated in 1919 and is headquartered in Amsterdam, the Netherlands.

www.corbion.com

2,573

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CRBN.AS

Performance Overview: CRBN.AS

Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CRBN.AS
2.37%
AEX-Index
11.18%

1-Year Return

CRBN.AS
34.28%
AEX-Index
14.77%

3-Year Return

CRBN.AS
59.27%
AEX-Index
22.70%

5-Year Return

CRBN.AS
24.23%
AEX-Index
53.58%

Compare To: CRBN.AS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CRBN.AS

Valuation Measures

Annual
As of 4/22/2024
  • Market Cap

    1.12B

  • Enterprise Value

    1.84B

  • Trailing P/E

    15.56

  • Forward P/E

    23.75

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.79

  • Price/Book (mrq)

    1.76

  • Enterprise Value/Revenue

    1.27

  • Enterprise Value/EBITDA

    8.97

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.05%

  • Return on Assets (ttm)

    3.95%

  • Return on Equity (ttm)

    11.55%

  • Revenue (ttm)

    1.44B

  • Net Income Avi to Common (ttm)

    72.9M

  • Diluted EPS (ttm)

    1.22

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    70.2M

  • Total Debt/Equity (mrq)

    123.47%

  • Levered Free Cash Flow (ttm)

    25.23M

Research Analysis: CRBN.AS

Analyst Price Targets

13.40 Low
24.40 Average
18.92 Current
30.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Company Insights: CRBN.AS

People Also Watch